Recursion Pharmaceuticals, Inc.RXRXNASDAQ
Loading
Year-over-year revenue growth rate
| Period | Value |
|---|---|
| Q4 2025 | 586.72% |
| Q3 2025 | -72.91% |
| Q2 2025 | 29.56% |
| Q1 2025 | 226.87% |
| Q4 2024 | -82.70% |
| Q3 2024 | 81.07% |
| Q2 2024 | 6.77% |
| Q1 2024 | 26.99% |
| Q4 2023 | 5.17% |
| Q3 2023 | -8.30% |
| Q2 2023 | -9.21% |
| Q1 2023 | -11.28% |
| Q4 2022 | 4.77% |
| Q3 2022 | 70.56% |
| Q2 2022 | 44.42% |
| Q1 2022 | 111.96% |
| Q4 2021 | 0.00% |
| Q3 2021 | 0.00% |
| Q2 2021 | 0.00% |
| Q1 2021 | -2.00% |
| Q4 2020 | 195.94% |
| Q3 2020 | 0.00% |
| Q2 2020 | 0.00% |
| Q1 2020 | 0.00% |